Grifols (GIKLY) Other Operating Expenses (2010 - 2019)

Grifols (GIKLY) posted Other Operating Expenses of -$351.5 million for Q1 2020, up 64.6% quarter-over-quarter from -$993.1 million in Q4 2019, and down 4.15% year-on-year from -$366.8 million in Q2 2019.

Grifols (GIKLY) Other Operating Expenses (2010 - 2019) Analysis & Trends

Grifols (GIKLY) has reported Other Operating Expenses for 9 consecutive years, with -$351.5 million the latest figure, recorded in Q1 2020.

  • Other Operating Expenses for Q1 2020 came in at -$351.5 million, down 4.15% year-over-year; the trailing twelve-month figure through Dec 2021 was -$351.5 million (up 73.85% YoY), and the FY2025 annual result was -$0.0, changed N/A from the prior year.
  • Other Operating Expenses was -$351.5 million for Q1 2020 at Grifols, up from -$993.1 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $0.0 in Q3 2016 and troughed at -$993.1 million in Q4 2019.
  • Average Other Operating Expenses over 5 years is -$459.5 million, with a median of -$337.5 million recorded in 2019.
  • Year-over-year, Other Operating Expenses plunged 4.1090625028680595e+17% in 2017 and increased 11.63% in 2018.
  • Over 5 years, Other Operating Expenses stood at -$0.0 in 2016, then slumped by 4.1090625028680595e+17% to -$979.7 million in 2017, then climbed by 11.63% to -$865.8 million in 2018, then fell by 14.7% to -$993.1 million in 2019, then soared by 64.6% to -$351.5 million in 2020.
  • Per Business Quant data, the three most recent Other Operating Expenses figures were -$351.5 million in Q1 2020, -$993.1 million in Q4 2019, and -$337.5 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Grifols - - -

Historic Data

Download Data
DateValue
Dec 31, 2019 -993.06 Mn
Dec 31, 2018 -865.76 Mn
Dec 31, 2017 -979.68 Mn
Dec 31, 2016 0.00
Dec 31, 2013 0.00
Jun 30, 2012 1.01 Mn
Mar 31, 2012 135,065.50
Dec 31, 2011 60.18 Mn
Sep 30, 2011 10.72 Mn
Jun 30, 2011 -430,948.46
Mar 31, 2011 422,558.32
Sep 30, 2010 570,742.50